Lobbying Filing Details

Total Spending

$30,000

Activities

1

Lobbyists

1

Gov't Entities

1

Filing Information

Filing UUID:: 01945273-1ff0-4683-93f1-24a1a16c1627
Type:: 4T - 4th Quarter - Termination
Period:: 2022 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:: January 20, 2023 at 1:23 AM
Income:: $30,000
Expenses:: $0
Termination Date:: December 31, 2022
Document URL:: View Submission

Quick Info

Document Type: text/html
Posted By: Darren Willcox

Registrant

W STRATEGIES, LLC

Government Affairs Consulting Firm.

Washington, District of Columbia

Client

STOKE THERAPEUTICS

Biotechnology company.

Massachusetts, United States of America

Lobbying Activities (1)

Activity 1

Health Issues

Education around innovation in neurological rare disease. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.

Lobbyists (1)

DARREN WILLCOX

Government Entities (1)

HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.